19 May 2013
Keywords: novartis, signs, 10-year, ab, drug, alliance, morphosys
Article | 10 December 2007
Swiss drug major Novartis has expanded its collaboration with German biotechnology company MorphoSys to create a broad R&D alliance ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 December 2007
3 December 2007
17 May 2013
© 2013 thepharmaletter.com